Dr. Norah Essali, MD

Dr. Essali practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Essali's NPI, 1497105571, was assigned on June 20, 2016. Dr. Essali holds Washington license MD61003237.

Dr. Essali's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Essali's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Essali to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Essali practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Essali's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Essali is licensed in Washington.

CMS data shows 65 Medicare services from Dr. Essali across 2 procedure codes in 2024, for 44 Medicare patients. Medicare paid $5,542 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Dr. Essali in 2024. The largest group is under 65, with 32 patients. 75% of them have anxiety, and 73% have alcohol and drug use disorders. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Essali's median patient age at 48, with 41% women.

In 2024, Dr. Essali wrote 453 Medicare Part D claims for 47 patients. 93% of them were for generic drugs. CMS names the drug for 357 of them, across 19 drugs with 11 or more claims each, at $117,293 in total drug cost. In 2023, CMS named 720 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Essali for performance year 2024, reported through an alternative payment model (APM). Dr. Essali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Essali, published from 2019 to 2020. 2019 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal, Immunotherapy and Psychotic Disorders. Dr. Essali has published most often in Brain Behav Immun. Dr. Essali's most frequent co-author is David Ryan Goldsmith, MD.

CMS Open Payments shows 1 general payment to Dr. Essali from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $25.